Close
ACHEMA MIDDLE EAST 2026

Monash University In Australia Leads $15M Mitochondrial Clinical Trial Drive

Almost 50 children in Australia are born every year with a devastating mitochondrial disease that has an expected lifespan of just 5 years. In...

Tumors Can Get Destroyed By Bacteria-Aid To Immune System

The introduction of bacteria to a tumor’s microenvironment goes on to create the possibility of acute inflammation, which further triggers the immune system’s primary...

Researchers Develop Revolutionary Treatment In Bone Cancer

Researchers from the University of East Anglia- UEA have come up with a new non-invasive treatment for bone cancer that happens to be effective...

Singapore Precision Drugs To Excel By Next-Gen Proteomics

The National University of Singapore’s Yong Loo Lin School of Medicine has gone on to launch the NUS Medicine Protein Biomarker Discovery Core Facility,...

Temperature Stable TB Vaccine Gives Out Immune Response

ID93+GLA-SE, a freeze-dried tuberculosis vaccine, was confirmed to be safe in the first clinical study of any subunit TB vaccine in a temperature-stable form. The...

T Cells Are Fruitful In Thwarting-Off Chronic Infections

In cases when the body is subjected to cancer as well as chronic infections, cytotoxic T immune cells happen to be vital in defining...

Randomness Drives Tumour Cells Response To Chemotherapy

A new weapon in the arsenal of cancer cells' treatment resistance, according to a study conducted by the Garvan Institute of Medical Research, is...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...